What to Expect From HCA Healthcare's Next Quarterly Earnings Report

Core Insights - HCA Healthcare, Inc. is a significant player in the healthcare services sector with a market capitalization of $107.7 billion and is set to announce its fiscal Q4 earnings for 2025 soon [1] Financial Performance - Analysts anticipate HCA to report a profit of $7.37 per share for the upcoming quarter, reflecting an 18.5% increase from $6.22 per share in the same quarter last year [2] - For the current fiscal year ending in December, HCA is expected to achieve a profit of $27.60 per share, which is a 25.7% increase from $21.96 per share in fiscal 2024, with further growth projected to $29.66 per share in fiscal 2026 [3] Stock Performance - HCA's shares have increased by 55.5% over the past 52 weeks, significantly outperforming the S&P 500 Index's 16% return and the State Street Health Care Select Sector SPDR ETF's 12.5% increase during the same period [4] Recent Developments - Following a better-than-expected Q3 earnings release, HCA's shares rose by 1.6%. The company reported total revenue of $19.2 billion, a 9.6% year-over-year increase, exceeding consensus expectations by 3.6%. Adjusted EPS improved by 42% from the previous year to $6.96, surpassing analyst estimates of $5.65 [5] - HCA has raised its fiscal 2025 guidance, now expecting revenue between $75 billion and $76.5 billion, and EPS between $27 and $28 [5] Analyst Ratings - Wall Street analysts maintain a "Moderate Buy" rating for HCA, with 14 out of 25 analysts recommending "Strong Buy," one suggesting "Moderate Buy," nine indicating "Hold," and one advising "Strong Sell." The mean price target for HCA is $486.41, suggesting a 3% potential upside from current levels [6]